Syndax Pharmaceuticals Statistics
NASDAQ: SNDXHealthcareBiotechnologyUSD
17.03-0.34 (-1.96%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Syndax Pharmaceuticals by the numbers
Syndax Pharmaceuticals has a market capitalization of $1.52 billion based on 89.30M shares outstanding. With trailing EPS of $-2.52, Syndax Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 11.1% below its 50-day average and 18.3% below its 200-day average.
Average daily trading volume is 1.54M shares, or about $26.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
SNDX valuation vs. peer median
| Metric | SNDX | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.52B | $1.47B | +3% |
| Avg. volume | 1.54M | 689.48K | +124% |
Peer median across 8 companies: STOK, INVA, IMCR, RAPP, RARE, MAZE, GHRS, TSHA.
Valuation
- Market cap
- $1.52B
- EPS (TTM)
- $-2.52
- Shares outstanding
- 89.30M
Price and trading
- Previous close
- 17.37
- Open
- 17.17
- Day range
- 17.03 – 17.70
- 52-week range
- 12.99 – 25.59
- 52-week change
- +3.53%
- Beta
- —
- Volume
- 1.59M
- Average volume
- 1.54M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 2, 2026
Additional statistics
- Market Cap
- 1.52B
- Forward Pe
- -19.94
- Eps
- -2.52
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 25.59
- Week52 Low
- 12.99
- Avg Volume
- 1.54M
- Shares Outstanding
- 89.30M
- Ma50
- 19.15
- Ma200
- 20.84
- Earnings Date
- Nov 2, 2026
- Pct From52w High
- -33.45%
- Pct From52w Low
- 31.10%